VitMode

Hypogonadism — Diagnosis and Criteria for TRT Eligibility

Not every low testosterone result means hypogonadism requiring treatment. We explain which laboratory and symptomatic criteria must be met before TRT becomes a justified option.

PZdr Piotr ZielińskiReviewed by dr Anna KowalczykUpdated: August 3, 2026
Strong evidence
4.6

Number of studies

2

Safety

Moderate

Time to effects

Not applicable — a diagnostic pathway.

Who it's for

Men with symptoms suggesting testosterone deficiency (reduced libido, erectile dysfunction, chronic fatigue, infertility)Physicians differentiating the cause of low testosterone before TRT eligibility
Table of contents

TL;DR

Not every low testosterone result means hypogonadism requiring treatment. We explain which laboratory and symptomatic criteria must be met before TRT becomes a justified option.

  • →Allows real hypogonadism to be distinguished from a transiently low result
  • →The primary/secondary distinction points to the direction of further diagnostic workup
  • →Reveals reversible secondary causes (obesity, sleep apnea, stress) that can be treated without TRT
Type of interventionDiagnostic pathway, not a therapy
Level of evidenceStrong — based on Endocrine Society guidelines
Target groupMen with symptoms suggesting testosterone deficiency
Time to effectsNot applicable — diagnostics, not treatment
Preparation requiredMorning blood test, repeated for confirmation
StatusStandard clinical pathway before TRT eligibility

Understand

Overview

Hypogonadism is a clinical condition in which the testes fail to produce enough testosterone — it's divided into primary (a problem at the level of the testes themselves, with high LH/FSH as a compensatory pituitary response) and secondary (a problem at the level of the pituitary or hypothalamus, with low or inappropriately normal LH/FSH). This distinction has key clinical importance because it points to a different direction for further diagnostic workup.

Diagnosis doesn't rely on a number alone — Endocrine Society guidelines require a combination of a reduced testosterone concentration, confirmed on at least two separate morning measurements, together with specific clinical symptoms such as reduced libido, erectile dysfunction, decreased muscle mass, or infertility. A low result alone without symptoms rarely justifies a diagnosis.

Diagnostic workup makes sense in men with genuine symptoms suggesting a deficiency, not as routine screening without indications. It's worth remembering that many co-existing conditions — obesity, sleep apnea, chronic stress, hypothyroidism — secondarily lower testosterone, and treating them can reverse the problem without the need for TRT.

Mechanism of action

Regulation of testosterone production runs along the hypothalamic-pituitary-testicular axis. The hypothalamus pulsatile releases gonadotropin-releasing hormone (GnRH), which stimulates the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH stimulates Leydig cells in the testes to produce testosterone, while FSH supports spermatogenesis in Sertoli cells.

High testosterone levels, in turn, inhibit GnRH and LH secretion through negative feedback, closing the regulatory loop. It's precisely the behavior of LH and FSH at low testosterone that allows the problem to be localized: elevated values point to damage in the testes themselves (the body is trying to 'push' them), while low or inappropriately normal values point to a disorder higher up, at the level of the pituitary or hypothalamus.

1

The hypothalamus secretes GnRH

Pulsatile release of gonadotropin-releasing hormone initiates the entire hormonal axis.

2

The pituitary responds with LH and FSH

LH stimulates Leydig cells to produce testosterone, FSH supports spermatogenesis.

3

The testes produce testosterone

Leydig cells synthesize testosterone under the influence of LH.

4

Negative feedback

High testosterone inhibits GnRH and LH secretion, closing the regulatory loop.

Evidence: strong — based on 2 studies in this database.

Benefits

Allows real hypogonadism to be distinguished from a transiently low result
The primary/secondary distinction points to the direction of further diagnostic workup
Reveals reversible secondary causes (obesity, sleep apnea, stress) that can be treated without TRT
Prevents unnecessary initiation of hormone therapy in people without a genuine indication

Common myths

MythEvery man with a testosterone result below normal has hypogonadism and qualifies for TRT.

FactDiagnosis requires a combination of a low result, confirmed twice, with genuine clinical symptoms — a result alone without symptoms isn't enough.

MythLH and FSH aren't needed, testosterone alone is enough.

FactLH and FSH are key to distinguishing primary from secondary hypogonadism, which changes the further diagnostic and therapeutic approach.

Forms & variants

Hypogonadism — Diagnosis and Criteria for TRT Eligibility comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.

Primary hypogonadism

A problem at the level of the testes, high LH/FSH.

Best for: Requires further diagnostic workup of the cause of testicular damage

Secondary hypogonadism

A problem at the level of the pituitary or hypothalamus, low or inappropriate LH/FSH.

Best for: Requires pituitary imaging and evaluation of other hormonal axes

Functional hypogonadism (reversible)

Secondary to obesity, sleep apnea, or chronic stress.

Best for: Potentially reversible without TRT after treating the underlying cause

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Practice

Frequently asked questions

No — guidelines require confirmation on at least two separate morning measurements, combined with clinical symptoms.

Primary results from a problem in the testes themselves (high LH/FSH as an attempt at compensation), secondary from a disorder at the level of the pituitary or hypothalamus (low or inappropriately normal LH/FSH).

Not always — functional hypogonadism, secondary to obesity or sleep apnea, can be reversible after treating the underlying cause, without the need for hormone therapy.

Dosage & timing

Typical dose

Not applicable — this entry describes a diagnostic pathway, not dosing

Form

Blood tests: total testosterone (2x morning), LH, FSH, optionally free testosterone and SHBG

A single abnormal result should never be the basis for a diagnosis or a treatment decision.

Best times to take it

  • Measurement always in the morning, between 7:00 and 10:00, due to the daily rhythm of testosterone secretion

Safety

Side effects & contraindications

Possible side effects

Not applicable — a diagnostic process, not a pharmacological intervention

Contraindications

Not applicable

Interactions

Some drugs (opioids, glucocorticosteroids) can lower testosterone independently of true hypogonadism — worth including in the history before diagnostic workup

Is it worth taking?

Who it's for

  • Men with symptoms suggesting testosterone deficiency (reduced libido, erectile dysfunction, chronic fatigue, infertility)
  • Physicians differentiating the cause of low testosterone before TRT eligibility

Not for

  • Not applicable

Evidence

Worth knowing

Testosterone has a daily rhythm — the highest concentrations occur in the morning, which is why a reliable measurement must be taken within that time window.

Obesity, sleep apnea and chronic stress are among the most common reversible causes of secondarily lowered testosterone.

Studies

Diagnosing hypogonadism requires clear-cut clinical symptoms combined with low testosterone concentration confirmed on at least two separate morning measurements.

Bhasin S et al. (Endocrine Society guidelines), Journal of Clinical Endocrinology & Metabolism, 2018

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline

Strong evidence

Bhasin S, Brito JP, Cunningham GR, et al. · Journal of Clinical Endocrinology & Metabolism · 2018

Clinical guidelines defining the diagnostic criteria for hypogonadism and the principles for differentiating the primary and secondary forms.

View study

Effects of Testosterone Treatment in Older Men (The Testosterone Trials)

Strong evidence

Snyder PJ, Bhasin S, Cunningham GR, et al. · New England Journal of Medicine · 2016

A set of large, randomized studies (the Testosterone Trials) evaluating the effects of testosterone therapy in older men with confirmed low hormone levels.

View study

Sources & bibliography

Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.

Compare with similar entries

About the authors of this entry

PZ

Author

dr Piotr Zieliński

Endocrinologist

Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.

268 publications on this site

AK

Medical review

dr Anna Kowalczyk

Editor-in-Chief, Molecular Biology

Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.

196 publications on this site

Published: August 3, 2026Updated: August 3, 2026

Related entries

Umięśniony sportowiec w stroju treningowym4.7

Testosterone

The primary anabolic hormone — its natural level depends heavily on sleep, resistance training, body composition and fat mass.

HormonyStrong evidence
Strzykawka i leki na jasnej powierzchni4.4

TRT — Administration Forms: Injections, Gels, and Patches

Injections, transdermal gels, and patches — the three main forms of testosterone replacement therapy differ in blood-concentration profile, ease of use, and the risk of transferring the hormone to other people.

TRTStrong evidence
Lekarz mierzący ciśnienie krwi pacjenta w gabinecie4.7

TRT — Side Effects and Therapy Monitoring

Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.

TRTStrong evidence
Lekarz sprawdzający parametry zdrowotne pacjenta podczas konsultacji4.5

Clomiphene in Men

Clomiphene citrate — known in Poland under the brand name Clostilbegyt — raises testosterone through a completely different route than TRT: instead of supplying the hormone from outside, it tricks the brain into making the testes produce more of their own. That makes it attractive to men who care about fertility, but the popular claim that it's simply a 'fertility drug' needs to be checked against the actual data.

TRTModerate evidence
Lekarz w białym fartuchu podczas konsultacji medycznej online4.7

TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?

TRT isn't a supplement for fatigue — it's pharmacological treatment for a confirmed testosterone deficiency, with a real but limited list of benefits and an equally real list of people who simply don't qualify for it.

TRTModerate evidence
Próbki krwi w probówkach na jasnym tle laboratoryjnym4.7

What Tests Are Needed Before TRT? The Complete Pre-Treatment Testing List

Before a physician can qualify a patient for testosterone therapy, a far broader panel of tests is needed than testosterone level alone. The full list of blood tests, symptom questionnaires, and criteria that determine whether TRT is safe and appropriate.

TRTStrong evidence
Zbliżenie brodatego mężczyzny ziewającego z dłonią przy ustach4.7

Can High SHBG Cause Symptoms of Testosterone Deficiency?

Yes — high SHBG can produce a fully symptomatic picture of testosterone deficiency, even when the total testosterone result looks normal. We explain why symptoms should lead to checking free testosterone, not to dismissing the diagnosis.

TRTModerate evidence
Mężczyzna podczas konsultacji lekarskiej w gabinecie4.6

Testosterone — What's Normal for a Man? Results, Age, and When It Becomes a Problem

The 'normal' range printed on your lab report doesn't mean quite what it seems — reference ranges vary between labs, assay methods, and the population they were derived from. We explain how to actually read a testosterone result, how it changes with age, and when a 'low-normal' result is already a clinical problem.

TRTModerate evidence

Related articles

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.